全文获取类型
收费全文 | 4596篇 |
免费 | 337篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 36篇 |
儿科学 | 161篇 |
妇产科学 | 140篇 |
基础医学 | 696篇 |
口腔科学 | 82篇 |
临床医学 | 578篇 |
内科学 | 871篇 |
皮肤病学 | 60篇 |
神经病学 | 639篇 |
特种医学 | 120篇 |
外科学 | 354篇 |
综合类 | 44篇 |
一般理论 | 6篇 |
预防医学 | 549篇 |
眼科学 | 110篇 |
药学 | 242篇 |
中国医学 | 10篇 |
肿瘤学 | 244篇 |
出版年
2023年 | 32篇 |
2022年 | 64篇 |
2021年 | 121篇 |
2020年 | 87篇 |
2019年 | 92篇 |
2018年 | 109篇 |
2017年 | 90篇 |
2016年 | 91篇 |
2015年 | 127篇 |
2014年 | 146篇 |
2013年 | 191篇 |
2012年 | 321篇 |
2011年 | 324篇 |
2010年 | 168篇 |
2009年 | 154篇 |
2008年 | 277篇 |
2007年 | 303篇 |
2006年 | 287篇 |
2005年 | 280篇 |
2004年 | 285篇 |
2003年 | 238篇 |
2002年 | 229篇 |
2001年 | 51篇 |
2000年 | 50篇 |
1999年 | 49篇 |
1998年 | 57篇 |
1997年 | 38篇 |
1996年 | 33篇 |
1995年 | 29篇 |
1994年 | 24篇 |
1993年 | 27篇 |
1992年 | 28篇 |
1991年 | 29篇 |
1990年 | 20篇 |
1989年 | 20篇 |
1988年 | 24篇 |
1986年 | 21篇 |
1985年 | 18篇 |
1984年 | 24篇 |
1983年 | 16篇 |
1982年 | 21篇 |
1981年 | 20篇 |
1979年 | 30篇 |
1978年 | 17篇 |
1977年 | 14篇 |
1975年 | 16篇 |
1974年 | 15篇 |
1973年 | 20篇 |
1972年 | 13篇 |
1971年 | 13篇 |
排序方式: 共有4942条查询结果,搜索用时 15 毫秒
91.
Nicole Villafane-Ferriol George Van Buren Jose E. Mendez-Reyes Amy L. McElhany Nader N. Massarweh Eric J. Silberfein Cary Hsu Hop S. Tran Cao Carl Schmidt Nicholas J. Zyromski Mary E. Dillhoff Alexandra Roch Evelyn Oliva Alexander C. Smith Qianzi Zhang William E. Fisher 《HPB : the official journal of the International Hepato Pancreato Biliary Association》2018,20(6):514-520
Background
Although used as criterion for early drain removal, postoperative day (POD) 1 drain fluid amylase (DFA) ≤ 5000 U/L has low negative predictive value for clinically relevant postoperative pancreatic fistula (CR-POPF). It was hypothesized that POD3 DFA ≤ 350 could provide further information to guide early drain removal.Methods
Data from a pancreas surgery consortium database for pancreatoduodenectomy and distal pancreatectomy patients were analyzed retrospectively. Those patients without drains or POD 1 and 3 DFA data were excluded. Patients with POD1 DFA ≤ 5000 were divided into groups based on POD3 DFA: Group A (≤350) and Group B (>350). Operative characteristics and 60-day outcomes were compared using chi-square test.Results
Among 687 patients in the database, all data were available for 380. Fifty-five (14.5%) had a POD1 DFA > 5000. Among 325 with POD1 DFA ≤ 5000, 254 (78.2%) were in Group A and 71 (21.8%) in Group B. Complications (35 (49.3%) vs 87 (34.4%); p = 0.021) and CR-POPF (13 (18.3%) vs 10 (3.9%); p < 0.001) were more frequent in Group B.Conclusions
In patients with POD1 DFA ≤ 5000, POD3 DFA ≤ 350 may be a practical test to guide safe early drain removal. Further prospective testing may be useful. 相似文献92.
Incidence of thrombotic stent occlusion during the first three months after sirolimus-eluting stent implantation in 500 consecutive patients 总被引:6,自引:0,他引:6
Regar E Lemos PA Saia F Degertekin M Tanabe K Lee CH Arampatzis CA Hoye A Sianos G de Feyter P van der Giessen WJ Smits PC van Domburg RT Serruys PW 《The American journal of cardiology》2004,93(10):1271-1275
Sirolimus-eluting stents have been used in our institution for all percutaneous interventions, without clinical or anatomic exclusion criteria, as part of the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital registry. We analyzed the incidence of (sub)acute stent thrombosis after sirolimus-eluting stent implantation in an unselected population of 510 consecutive patients. At 3-month follow-up, (sub)acute stent thrombosis was diagnosed in 2 patients (0.4%) 6 hours and 11 days after the procedure, respectively. These cases occurred in diabetic women with complex coronary lesions. Intravascular ultrasound examination showed inadequate stent expansion and uncovered distal dissection as possible mechanical explanations for the thrombosis. 相似文献
93.
Hanne D. Heerkens Lisanne van Berkel Dorine S.J. Tseng Evelyn M. Monninkhof Hjalmar C. van Santvoort Jeroen Hagendoorn Inne H.M. Borel Rinkes Irene M. Lips Martijn Intven I. Quintus Molenaar 《HPB : the official journal of the International Hepato Pancreato Biliary Association》2018,20(2):188-195
Background
Surgery for pancreatic cancer yields significant morbidity and mortality risks and survival is limited. Therefore, the influence of complications on quality of life (QoL) after pancreatic surgery is important. This study compares QoL in patients with and without severe complications after surgery for pancreatic (pre-)malignancy.Methods
This prospective cohort study scored complications after pancreatic surgery according to the Clavien–Dindo system and the definitions of the International Study Group of Pancreatic Surgery. QoL was measured by the RAND36 questionnaire, the European Organization for Research and Treatment of Cancer core questionnaire (QLQ-C30) and the pancreas specific QLQ-PAN26. QoL in patients with severe complications was compared with QoL in patients with no or mild complications over a period of 12 months. Analysis was performed with linear mixed models for repeated measurements.Results
Between March 2012 and July 2016, 137 patients were included. Sixty-eight patients (50%) had at least 1 severe complication. There were no statistically significant and clinically relevant differences between both groups in QoL up to 12 months after surgery.Conclusion
In this study, no differences in QoL between patients with and without severe postoperative complications were encountered during the first 12 months after surgery for pancreatic (pre-)malignancy.94.
Vernica Frana Diniz Rocha Thiago Pereira Cavalcanti Jailton Azevedo Helena Ferreira Leal Giulyana Evelyn Oliveira Silva Allan Roberto Xavier Malheiros Ledilce Almeida Ataide Jos Admiro Lima Filho Antonio Raimundo Pinto Almeida Nadia de Andrade Khouri Mitermayer Galvo Reis Joice Neves Reis 《The American journal of tropical medicine and hygiene》2021,104(3):848
95.
96.
Saidy Vásconez Noguera Evelyn Patrícia Sánchez Espinoza Marina Farrel Côrtes Izabel Cristina Vilela Oshiro Fernanda de Sousa Spadão Laura Maria Brasileiro Brandão Ana Natiele da Silva Barros Sibeli Costa Bianca Leal de Almeida Paula Gemignani Soriano Alessandra Grassi Salles Mirian Elizabete Marques Escorcio Cristina Madeira Barretti Fernanda Spadotto Baptista Glaura Souza Alvarenga Igor Marinho Leila Suemi Harima Letaif Ho Ye Li Silvia Figueiredo Costa 《American journal of infection control》2021,49(4):512-515
97.
Karnopp Thaís Evelyn Freitas Eduarda Correa Rieger Alexandre Chapacais Gustavo Flores Monticielo Odirlei André 《Clinical rheumatology》2022,41(6):1859-1866
Clinical Rheumatology - Patients with systemic lupus erythematosus (SLE) may have neurological complications, characterizing neuropsychiatric lupus (NPSLE). Studies have investigated alternative... 相似文献
98.
99.
100.
Aoki J Serruys PW van Beusekom H Ong AT McFadden EP Sianos G van der Giessen WJ Regar E de Feyter PJ Davis HR Rowland S Kutryk MJ 《Journal of the American College of Cardiology》2005,45(10):1574-1579
OBJECTIVES: This study was designed to evaluate whether rapid endothelialization of stainless steel stents with a functional endothelium prevents stent thrombosis and reduces the restenotic process. BACKGROUND: A "pro-healing" approach for prevention of post-stenting restenosis is theoretically favored over the use of cytotoxic or cytostatic local pharmacologic therapies. It is believed that the central role of the vascular endothelium is to maintain quiescence of the underlying media and adventitia. METHODS: Sixteen patients with de novo coronary artery disease were successfully treated with implantation of endothelial progenitor cell (EPC) capture stents. RESULTS: Complete procedural and angiographic success was achieved in all 16 patients. The nine-month composite major adverse cardiac and cerebrovascular events (MACCE) rate was 6.3% as a result of a symptom-driven target vessel revascularization in a single patient. There were no other MACCE despite only one month of clopidogrel treatment. At six-month follow-up, mean angiographic late luminal loss was 0.63 +/- 0.52 mm, and percent stent volume obstruction by intravascular ultrasound analysis was 27.2 +/- 20.9%. CONCLUSIONS: This first human clinical investigation of this technology demonstrates that the EPC capture coronary stent is safe and feasible for the treatment of de novo coronary artery disease. Further developments in this technology are warranted to evaluate the efficacy of this device for the treatment of coronary artery disease. 相似文献